Bo Gamble, compares and contrasts the definition of value and quality as it relates to cancer care

Bo Gamble, compares and contrasts the definition of value and quality as it relates to cancer care

01:59 |

Related Videos

Charles Rudin, MD, PhD, shares the take home message regarding Keynote-604 for lung cancer treatment

0:46

Charles Rudin, MD, PhD, shares the take home message regarding Keynote-604 for lung cancer treatment

Next-Gen Sequencing is Transforming Oncology Practices

4:27

Next-Gen Sequencing is Transforming Oncology Practices

Charles Loprinzi, MD, explains the role of palliative and supportive care in medical oncology

2:41

Charles Loprinzi, MD, explains the role of palliative and supportive care in medical oncology

William K. Oh, MD, considers the role of PARP inhibitors in mCRPC

2:37

William K. Oh, MD, considers the role of PARP inhibitors in mCRPC

Edward Kim, MD, describes how immunotherapy combinations will be used in the near future

1:36

Edward Kim, MD, describes how immunotherapy combinations will be used in the near future

Kim N. Chi, MD, on what findings from the Phase III TITAN study mean for patients

0:58

Kim N. Chi, MD, on what findings from the Phase III TITAN study mean for patients

Johnetta Blakely, MD, reflects on the progress and innovation of community oncologists

2:19

Johnetta Blakely, MD, reflects on the progress and innovation of community oncologists

Daniel M. Geynisman, MD, on how real-world analysis influences clinical decision-making

2:20

Daniel M. Geynisman, MD, on how real-world analysis influences clinical decision-making

Debra Patt, MD, PhD, MBA, on the promising investigations of CDK4/6 inhibitors

0:54

Debra Patt, MD, PhD, MBA, on the promising investigations of CDK4/6 inhibitors

Bo Gamble, compares and contrasts the definition of value and quality as it relates to cancer care

1:59

Bo Gamble, compares and contrasts the definition of value and quality as it relates to cancer care

Alexander Spira, MD, PhD, FACP, on managing lung cancer patients in a community setting

0:50

Alexander Spira, MD, PhD, FACP, on managing lung cancer patients in a community setting

Jeff Vacirca, MD, explains why OneOncology is a unique practice model

0:52

Jeff Vacirca, MD, explains why OneOncology is a unique practice model

Will NGS-Based Cancer Tests Become Routine?

3:23

Will NGS-Based Cancer Tests Become Routine?

Russell Gollard, MD, explains how IDNs effectively coordinate cancer care

1:44

Russell Gollard, MD, explains how IDNs effectively coordinate cancer care

Christopher J. Kane MD, FACS, on trends in the multimodality treatment of localized prostate cancer

2:55

Christopher J. Kane MD, FACS, on trends in the multimodality treatment of localized prostate cancer

Hani Babiker, MD, describes the setting of FDA approval on tumor treatment fields

0:19

Hani Babiker, MD, describes the setting of FDA approval on tumor treatment fields

The impact of clinical pathways on quality cancer care as explained by Bruce Gould, MD

0:37

The impact of clinical pathways on quality cancer care as explained by Bruce Gould, MD

Erika Hamilton, MD, on how CDK4/6 inhibitors transformed the management of metastatic breast cancer

1:12

Erika Hamilton, MD, on how CDK4/6 inhibitors transformed the management of metastatic breast cancer

Dana Chase, MD, shares details about PRIMA and PAOLA clinical studies regarding ovarian cancer

5:14

Dana Chase, MD, shares details about PRIMA and PAOLA clinical studies regarding ovarian cancer

Erin Stevens, MD, on why oncologists should be concerned about sexual health in their patients

0:18

Erin Stevens, MD, on why oncologists should be concerned about sexual health in their patients